Table 1.
Details of different M. anisopliae–chitosan nanoparticles and M. anisopliae treatments used in the bio-activity studies.
| Treatments | Treatment Description | Concentration |
|---|---|---|
| T1 | M. anisopliae–chitosan nanoparticles | 31.25 ppm |
| T2 | M. anisopliae–chitosan nanoparticles | 62.5 ppm |
| T3 | M. anisopliae–chitosan nanoparticles | 125 ppm |
| T4 | M. anisopliae–chitosan nanoparticles | 250 ppm |
| T5 | M. anisopliae–chitosan nanoparticles | 500 ppm |
| T6 | M. anisopliae conidial suspension | 106 conidia/ml |
| T7 | Chitosan nanoparticles | 200 ppm |
| T8 | Control (ddH2O) | 0 |